Skip to main content
. 2023 Jun 1;279(3):479–485. doi: 10.1097/SLA.0000000000005935

TABLE 5.

Univariable Analysis of Risk Factors With Regard to the Morbidity Defined as Missing a Textbook Outcome

Parameters Category n (%) Event [n (%)] OR 95% CI P
Sex Male 1011 (47.4) 349 (34.5) 1
Female 1124 (52.6) 333 (29.6) 0.799 0.665–0.958 0.0155
Age <50 yr 437 (20.5) 130 (29.7) 0.875 0.687–1.110 0.2854
50–69 yr 1128 (52.8) 369 (32.6) 1
≥70 yr 570 (26.7) 184 (32.3) 0.984 0.793–1.220 0.6359
ASA classification ASA I/II 1394 (66.7) 405 (29.1) 1
ASA III/IV 697 (33.3) 263 (37.7) 1.480 1.221–1.792 <0.0001
Diabetes mellitus No 1756 (82.2) 548 (31.2) 1
Yes 379 (17.8) 134 (35.4) 1.206 0.953–1.521 0.1165
CHD/heart failure No 1986 (93.0) 620 (31.22) 1
Yes 149 (7.0) 62 (41.6) 1.570 1.115–2.200 0.0091
Previous history of pancreatitis No 1923 (90.1) 616 (32.0) 1
Yes 212 (9.9) 66 (31.1) 0.959 0.703–1.297 0.7907
BMI <25 1078 (51.3) 324 (30.1) 1
25 to <30 716 (34.0) 237 (33.1) 1.151 0.940–1.410 0.1732
≥30 309 (14.7) 111 (35.9) 1.305 0.998–1.700 0.0504
Neoadjuvant therapy No 1861 (87.2) 591 (31.8) 1
Yes 274 (12.8) 91 (33.2) 1.069 0.813–1.396 0.6298
Carcinoma No 1077 (50.4) 309 (28.7) 1
Yes 1058 (59.6) 373 (35.3) 1.353 1.128–1.625 0.0012
DP type Type 1 1383 (64.8) 370 (26.8) 1
Type 2 79 (3.7) 34 (43.0) 2.069 1.297–3.272 0.0020
Type 3 604 (28.3) 248 (41.1) 1.907 1.559–2.332 <0.0001
Type 4 69 (3.2) 30 (43.5) 2.106 1.281–3.431 0.0029
Splenectomy No 382 (17.9) 104 (27.2) 1
Yes 1753 (82.1) 578 (33.0) 1.315 1.031–1.688 0.0294
Operation time ≤195 min 1105 (51.8) 277 (25.1) 1
196–240 min 441 (20.7) 153 (34.7) 1.588 1.250–2.015 0.0001
>240 min 587 (27.5) 252 (42.9) 2.248 1.818–2.782 <0.0001
Estimated blood loss <500 mL 848 (40.4) 199 (23.5) 1
500–1000 mL 818 (38.9) 270 (33.0) 1.668 1.339–2.081 <0.0001
>1000 mL 435 (20.7) 202 (46.4) 2.934 2.285–3.774 <0.0001

BMI indicate body mass index; CHD, coronary heart disease.